3.2593
1.81%
-0.0607
前日終値:
$3.32
開ける:
$3.25
24時間の取引高:
104.64K
Relative Volume:
0.49
時価総額:
$167.32M
収益:
$81.06M
当期純損益:
$-55.55M
株価収益率:
-2.859
EPS:
-1.14
ネットキャッシュフロー:
$-47.98M
1週間 パフォーマンス:
-6.59%
1か月 パフォーマンス:
-16.62%
6か月 パフォーマンス:
-46.99%
1年 パフォーマンス:
-36.94%
Sight Sciences Inc Stock (SGHT) Company Profile
SGHT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.27 | 167.32M | 81.06M | -55.55M | -47.98M | -1.14 |
ABT
Abbott Laboratories
|
112.48 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
BSX
Boston Scientific Corp
|
95.44 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
365.87 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
MDT
Medtronic Plc
|
81.34 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
73.34 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-06 | 開始されました | UBS | Buy |
2024-11-04 | ダウングレード | Lake Street | Buy → Hold |
2024-08-21 | 開始されました | Lake Street | Buy |
2023-09-12 | ダウングレード | BofA Securities | Neutral → Underperform |
2023-09-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
2023-09-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
2023-08-24 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2023-07-10 | ダウングレード | Citigroup | Buy → Neutral |
2023-01-06 | アップグレード | Stifel | Hold → Buy |
2022-10-04 | 開始されました | Needham | Hold |
2022-07-26 | 開始されました | Stifel | Hold |
2022-02-03 | 開始されました | William Blair | Outperform |
2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Sight Sciences Inc (SGHT) 最新ニュース
Sight sciences CTO David Badawi sells shares worth $12,478 By Investing.com - Investing.com Australia
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,829 Shares of Stock - MarketBeat
Sight sciences CTO David Badawi sells shares worth $12,478 - Investing.com
Sight sciences chief legal officer Jeremy Hayden sells $5,898 in stock - Investing.com
OMNI Surgical System shows promise in glaucoma care By Investing.com - Investing.com South Africa
Sight Sciences stock hits 52-week low at $3.29 amid market challenges - Investing.com Canada
OMNI Surgical System shows promise in glaucoma care - Investing.com India
Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma - The Manila Times
Sight Sciences Announces Real-World 36-Month Study - GlobeNewswire
Sight Sciences (SGHT) Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System - StreetInsider.com
Sight Sciences' OMNI System Shows Breakthrough 3-Year Success in Landmark Glaucoma Study - StockTitan
Sight Sciences CTO David Badawi sells $10,956 in stock By Investing.com - Investing.com Nigeria
Sight sciences CEO Paul Badawi sells $44,012 in stock - Investing.com India
Sight sciences chief legal officer sells shares worth $17,131 - Investing.com India
Sight sciences chief legal officer sells shares worth $17,131 By Investing.com - Investing.com Nigeria
Sight sciences CFO Alison Bauerlein sells shares worth $35,579 By Investing.com - Investing.com Nigeria
Sight sciences CEO Paul Badawi sells $44,012 in stock By Investing.com - Investing.com South Africa
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells 12,236 Shares of Stock - MarketBeat
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,111 Shares of Stock - MarketBeat
Sight sciences CFO Alison Bauerlein sells shares worth $35,579 - Investing.com India
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $17,121.28 in Stock - MarketBeat
Sight Sciences CTO David Badawi sells $10,956 in stock - Investing.com India
Geode Capital Management LLC Raises Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Barclays PLC Increases Stock Holdings in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Receives $5.12 Consensus Target Price from Brokerages - MarketBeat
State Street Corp Increases Stock Position in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of “Hold” by Brokerages - Defense World
Sight Sciences Announces the Results of a Budget Impact - GlobeNewswire
Sight Sciences' TearCare System Shows Major Cost Savings Over Traditional Dry Eye Treatments in New Study - StockTitan
Citigroup Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World
Sight Sciences secures $5 million in additional loan funding - Investing.com
Sight Sciences secures $5 million in additional loan funding By Investing.com - Investing.com UK
Where Sight Sciences Stands With Analysts - Benzinga
Sight sciences EVP Manohar Raheja acquires $19,250 in stock - Investing.com
Sight sciences EVP Manohar Raheja acquires $19,250 in stock By Investing.com - Investing.com UK
Sight Sciences (NASDAQ:SGHT) Research Coverage Started at UBS Group - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Sight Sciences (NASDAQ:SGHT) Coverage Initiated at UBS Group - MarketBeat
Sight Sciences initiated with a Buy at UBS - Yahoo Finance
UBS Initiates Coverage of Sight Sciences (SGHT) with Buy Recommendation - Nasdaq
UBS starts Sight Sciences stock coverage, forecasts strong sales growth by 2026 - Investing.com
UBS Starts Sight Sciences Inc. (SGHT) at Buy - StreetInsider.com
Sight sciences EVP Manohar Raheja buys $13,132 in stock By Investing.com - Investing.com Canada
Sight sciences EVP Manohar Raheja buys $13,132 in stock - Investing.com
Sight sciences EVP Manohar Raheja acquires $18,440 in stock By Investing.com - Investing.com Canada
Sight sciences EVP Manohar Raheja acquires $18,440 in stock - Investing.com
Millrace Asset Group Inc. Makes New Investment in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat
GSA Capital Partners LLP Invests $136,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Nano Dimension Leads 3 US Penny Stocks To Consider - Simply Wall St
Independent Chairman Of Sight Sciences Sold 25% Of Their Shares - Simply Wall St
Sight Sciences Inc (SGHT) 財務データ
収益
当期純利益
現金流量
EPS
Sight Sciences Inc (SGHT) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Badawi David | Chief Technology Officer |
Jan 08 '25 |
Sale |
3.26 |
3,829 |
12,479 |
1,749,541 |
大文字化:
|
ボリューム (24 時間):